AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 51 min read$ARCB

Gattis Erin K sold $863K of ARCB

Gattis Erin K (CHIEF HUMAN RESOURCES OFFICER) sold 6,163 shares of ARCBEST CORP /TX/ (ARCB) at $140.00 ($0.86M total) on 2026-08-04.

Original reporting
SEC EDGAR · Gattis Erin K
Published Aug 5, 2026, 9:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ARCB
Neutral
high confidence
Mentioned
$ARCB
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARCBNeutralLow
01

Why it matters

This is primarily a sentiment datapoint. Without accompanying company news, it is unlikely to change valuation drivers.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental information about ARCB’s business.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but it does not disclose motives, other holdings, or whether additional sales are planned.

Relevance 5/10Novelty 2/10Timing: filed 2026-08-05, transaction dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for ARCB, reported by the company’s CHRO.

Company-level read

Ticker impact

$ARCBNeutralHigh confidence
Context

ARCB Form 4 shows CHRO Erin K Gattis sold 6,163 shares on 2026-08-04 for about $862,820 at $140/share.

Expected impact

Likely minimal near-term price impact; any effect should be short-lived unless follow-on selling accelerates.

Evidence & confidence

The filing is a Form 4 insider transaction, not earnings, guidance, or a corporate action. The article provides sale size and price but no new company-specific operating or regulatory development.

Market effects

Sector

No clear sector read-through from a single CHRO open-market sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be driven by diversification or tax planning, so the signal may be overstated versus the mechanical need to sell.

Key entities

  • issuer
    ARCBEST CORP

    Company whose insider transaction is disclosed on Form 4.

  • insider
    Gattis Erin K

    Chief Human Resources Officer who sold shares.

Read at source← All news

Related articles

AUG 5
$ARCBMed

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

financialcontent.com4 min
AUG 1
$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

yahoo.com6 min
JUL 31
$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

yahoo.com5 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$ARCBMedAI 8/10

ArcBest’s Q2 a step on path to recovery

ArcBest's second-quarter results showed operational improvements in both of its business segments. It is benefitting from heavier shipment weights on the asset-based side of the house while cost initiatives have pushed its logistics offering back into profitability. Shipment weights increasing as TL freight returns ArcBest's (NASDAQ: ARCB) asset-based unit, which includes less-than-truckload subsidiary ABF Freight, reported a 10% y/y increase in revenue to $784 million.

yahoo.com4 min
JUL 29
$ARCBMed

ArcBest reports second quarter loss, affected by restructuring costs | Arkansas Democrat Gazette

ArcBest reported a Q2 GAAP loss of $13.8 million, or 62 cents per share, versus a year-ago profit of $25.8 million, or $1.12 per share. Revenue rose to $1.18 billion from $1.02 billion. Non-GAAP net income was $53.6 million, or $2.38 per diluted share. The results were tied to restructuring costs from a July 16 plan and included $40 million annualized savings.

arkansasonline.com6 min